ArticleAlcoholism, clinical and experimental research2019

Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.